title: Severe streptococcal cellulitis after subcutaneous pegylated interferon alfa-2B in a diabetic patient.
authors.forename: Fanny
authors.initials: F
authors.lastname: Lanternier
authors.forename: Cyriaque
authors.initials: C
authors.lastname: Bon
authors.forename: Nathalie
authors.initials: N
authors.lastname: Memain
authors.forename: Dominique
authors.initials: D
authors.lastname: Roulot
authors.forename: Olivier
authors.initials: O
authors.lastname: Lortholary
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002481:Cellulitis / Q000382:microbiology* / Q000628:therapy; D003920:Diabetes Mellitus; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D013290:Streptococcal Infections / Q000150:complications* / Q000209:etiology / Q000628:therapy; D000637:Transaminases / Q000097:blood
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D000637:Transaminases; C417083:peginterferon alfa-2b